NEW YORK (GenomeWeb News) – Nasdaq issued a warning to CombiMatrix on Monday telling the company it is not in compliance with a listing requirement calling for a minimum $2.5 million in stockholders' equity.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.
The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.
A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.
The US is heading toward another budget showdown, Nature News says.